HSTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
HealthStream Inc (HSTM) is not a strong buy at the moment for a beginner investor with a long-term perspective. The stock is currently in a bearish technical trend, with no significant positive catalysts or trading signals. Insiders are selling, and analysts have lowered price targets due to an uncertain healthcare environment. While the company has shown modest financial growth, the lack of strong upward momentum, combined with neutral hedge fund sentiment and no recent congress trading activity, makes this stock a hold for now.
The technical indicators suggest a bearish trend. The MACD is below zero and negatively contracting, the RSI is neutral at 22.308, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 19.715), with resistance levels at R1: 22.053 and R2: 22.775.
The company has shown modest financial growth in Q3 2025, with revenue up 4.62% YoY, net income up 6.31% YoY, and EPS up 5.26% YoY.
Insiders have increased selling activity by 146.37% in the last month. Analysts have lowered the price target from $28 to $25, citing an uncertain healthcare environment. The gross margin has dropped by 2.94% YoY. No significant hedge fund activity or congress trading data is available.
In Q3 2025, HealthStream reported revenue of $76.47M (up 4.62% YoY), net income of $6.09M (up 6.31% YoY), and EPS of 0.2 (up 5.26% YoY). However, the gross margin dropped to 51.19% (-2.94% YoY).
Canaccord has lowered the price target from $28 to $25 and maintained a Hold rating, reflecting concerns about an uncertain healthcare environment.
